Literature DB >> 19363806

Phenotype and 244k array-CGH characterization of chromosome 13q deletions: an update of the phenotypic map of 13q21.1-qter.

Maria Kirchhoff1, Anne-Marie Bisgaard, Radka Stoeva, Boyan Dimitrov, Gabriele Gillessen-Kaesbach, Jean-Pierre Fryns, Hanne Rose, Liliana Grozdanova, Ivan Ivanov, Kathelijn Keymolen, Christina Fagerberg, Lisbeth Tranebjaerg, Flemming Skovby, Margarita Stefanova.   

Abstract

Partial deletions of the long arm of chromosome 13 lead to variable phenotypes dependant on the size and position of the deleted region. In order to update the phenotypic map of chromosome 13q21.1-qter deletions, we applied 244k Agilent oligonucleotide-based array-CGH to determine the exact breakpoints in 14 patients with partial deletions of this region. Subsequently, we linked the genotype to the patient's phenotype. Using this approach, we were able to refine the smallest deletion region linked to short stature (13q31.3: 89.5-91.6 Mb), microcephaly (13q33.3-q34), cortical development malformations (13q33.1-qter), Dandy-Walker malformation (DWM) (13q32.2-q33.1), corpus callosum agenesis (CCA) (13q32.3-q33.1), meningocele/encephalocele (13q31.3-qter), DWM, CCA, and neural tube defects (NTDs) taken together (13q32.3-q33.1), ano-/microphthalmia (13q31.3-13qter), cleft lip/palate (13q31.3-13q33.1), lung hypoplasia (13q31.3-13q33.1), and thumb a-/hypoplasia (13q31.3-q33.1 and 13q33.3-q34). Based on observations of this study and previous reports we suggest a new entity, "distal limb anomalies association," linked to 13q31.3q33.1 segment. Most of the individuals with deletion of any part of 13q21qter showed surprisingly similar facial dysmorphic features, and thus, a "13q deletion facial appearance" was suggested. Prominent nasal columella was mapped between 13q31.3 and 13q33.3, and micrognathia between 13q21.33 and 13q31.1. The degree of mental delay did not display a particular phenotype-genotype correlation on chromosome 13. In contrast to previous reports of carriers of 13q32 band deletions as the most seriously affected patients, we present two such individuals with long-term survival, 28 and 2.5 years.

Entities:  

Mesh:

Year:  2009        PMID: 19363806     DOI: 10.1002/ajmg.a.32814

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  26 in total

1.  GPC5 gene and its related pathways in lung cancer.

Authors:  Yafei Li; Ping Yang
Journal:  J Thorac Oncol       Date:  2011-01       Impact factor: 15.609

2.  De Novo Mutations in CHAMP1 Cause Intellectual Disability with Severe Speech Impairment.

Authors:  Maja Hempel; Kirsten Cremer; Charlotte W Ockeloen; Klaske D Lichtenbelt; Johanna C Herkert; Jonas Denecke; Tobias B Haack; Alexander M Zink; Jessica Becker; Eva Wohlleber; Jessika Johannsen; Bader Alhaddad; Rolph Pfundt; Sigrid Fuchs; Dagmar Wieczorek; Tim M Strom; Koen L I van Gassen; Tjitske Kleefstra; Christian Kubisch; Hartmut Engels; Davor Lessel
Journal:  Am J Hum Genet       Date:  2015-09-03       Impact factor: 11.025

3.  13q22.1-q32.1 Microdeletion Syndrome.

Authors:  Ming-Wei Li; Xin-Yi Zou; Chao-Chun Zou
Journal:  Indian J Pediatr       Date:  2018-11-07       Impact factor: 1.967

4.  Growth hormone deficiency, aortic dilation, and neurocognitive issues in Feingold syndrome 2.

Authors:  Michael Muriello; Alexander Y Kim; Krista Sondergaard Schatz; Natalie Beck; Meral Gunay-Aygun; Julie E Hoover-Fong
Journal:  Am J Med Genet A       Date:  2019-01-23       Impact factor: 2.802

5.  Genomic characterization of prenatally detected chromosomal structural abnormalities using oligonucleotide array comparative genomic hybridization.

Authors:  Peining Li; Pawel Pomianowski; Miriam S DiMaio; Joanne R Florio; Michael R Rossi; Bixia Xiang; Fang Xu; Hui Yang; Qian Geng; Jiansheng Xie; Maurice J Mahoney
Journal:  Am J Med Genet A       Date:  2011-06-10       Impact factor: 2.802

6.  FGF17, a gene involved in cerebellar development, is downregulated in a patient with Dandy-Walker malformation carrying a de novo 8p deletion.

Authors:  Ginevra Zanni; Sabina Barresi; Lorena Travaglini; Laura Bernardini; Teresa Rizza; Maria Cristina Digilio; Eugenio Mercuri; Stefano Cianfarani; Massimiliano Valeriani; Alessandro Ferraris; Letizia Da Sacco; Antonio Novelli; Enza Maria Valente; Bruno Dallapiccola; Enrico Silvio Bertini
Journal:  Neurogenetics       Date:  2011-04-12       Impact factor: 2.660

7.  Deletion of Chromosome 13 due to Different Rearrangements and Impact on Phenotype.

Authors:  Fernanda T Bellucco; Hélio Rodrigues de Oliveira-Júnior; Roberta Santos Guilherme; Silvia Bragagnolo; Ana B Alvarez Perez; Vera Ayres Meloni; Maria I Melaragno
Journal:  Mol Syndromol       Date:  2019-03-06

8.  Computational method for estimating DNA copy numbers in normal samples, cancer cell lines, and solid tumors using array comparative genomic hybridization.

Authors:  Victor Abkevich; Diana Iliev; Kirsten M Timms; Thanh Tran; Mark Skolnick; Jerry S Lanchbury; Alexander Gutin
Journal:  J Biomed Biotechnol       Date:  2010-07-08

9.  Clinical characterization of individuals with deletions of genes in holoprosencephaly pathways by aCGH refines the phenotypic spectrum of HPE.

Authors:  Jill A Rosenfeld; Blake C Ballif; Donna M Martin; Arthur S Aylsworth; Bassem A Bejjani; Beth S Torchia; Lisa G Shaffer
Journal:  Hum Genet       Date:  2010-04       Impact factor: 4.132

Review 10.  Genetic factors in esophageal atresia, tracheo-esophageal fistula and the VACTERL association: roles for FOXF1 and the 16q24.1 FOX transcription factor gene cluster, and review of the literature.

Authors:  Charles Shaw-Smith
Journal:  Eur J Med Genet       Date:  2009-10-12       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.